Claudin-6 is of limited sensitivity and specificity for the diagnosis of atypical teratoid/rhabdoid tumors

Brain Pathology

Volumn 21, Issue 5, 2011, Pages 558-563

  Antonelli, Manila ^a   Hasselblatt, Martin ^b   Haberler, Christine ^c   Di Giannatale, Angela ^d   Garrè, Maria L ^d   Donofrio, Vittoria ^e   Lauriola, Libero ^f   Ridola, Vita ^f   Arcella, Antonella ^g   Frühwald, Michael ^h   Giangaspero, Felice ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d G GASLINI INSTITUTE   (Italy)

^e SANTOBONO PAUSILIPON CHILDREN S HOSPITAL   (Italy)

^f FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^g IRCCS NEUROMED   (Italy)

^h KLINIKUM AUGSBURG   (Germany)

Author keywords

atypical teratoid rhabdoid tumor; BAF47; brain tumor; claudin 6 protein; INI1 protein

Indexed keywords

CLAUDIN 6; TUMOR MARKER;

ARTICLE; ATYPICAL RHABDOID TUMOR; ATYPICAL TERATOID TUMOR; BRAIN TUMOR; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; DIAGNOSTIC ACCURACY; GENE EXPRESSION; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MEDULLOBLASTOMA; PROTEIN EXPRESSION; TUMOR DIAGNOSIS;

AUSTRIA; BRAIN NEOPLASMS; CHI-SQUARE DISTRIBUTION; CHROMOSOMAL PROTEINS, NON-HISTONE; CLAUDINS; DNA-BINDING PROTEINS; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; PEDIATRICS; RHABDOID TUMOR; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION FACTORS;

EID: 79958018765     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2011.00478.x     Document Type: Article

References (15)

1. Agarwal R, D'Souza T, Morin PJ, (2005) Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity. Cancer Res 65: 7378-7385. (Pubitemid 41161271)
2. Biegel JA, Zhou JY, Rorke LB, Stenstrom C, Wainwright LM, Fogelgren B, (1999) Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res 59: 74-79. (Pubitemid 29062960)
3. Biegel JA, Tan L, Zhang F, Wainwright L, Russo P, Rorke LB, (2002) Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Clin Cancer Res 8: 3461-3467. (Pubitemid 35340722)
4. Birks DK, Kleinschmidt-Demasters BK, Donson AM, Barton VN, McNatt SA, Foreman NK, Handler MH, (2010) Claudin 6 Is a Positive Marker for Atypical Teratoid/Rhabdoid Tumors. Brain Pathol 20: 140-150.
5. Bourdeaut F, Fréneaux P, Thuille B, Lellouch-Tubiana A, Nicolas A, Couturier J, et al, (2007) hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities. J Pathol 211: 323-330. (Pubitemid 46172708)
6. Frühwald MC, Hasselblatt M, Wirth S, Köhler G, Schneppenheim R, Subero JI, et al, (2006) Non-linkage of familial rhabdoid tumors to SMARCB1 implies a second locus for the rhabdoid tumor predisposition syndrome. Pediatr Blood Cancer 47: 273-278. (Pubitemid 44148043)
7. Haberler C, Laggner U, Slavc I, Czech T, Ambros IM, Ambros PF, et al, (2006) Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype. Am J Surg Pathol 30: 1462-1468. (Pubitemid 44655483)
8. Judkins AR, Mauger J, Ht A, Rorke LB, Biegel JA, (2004) Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms. Am J Surg Pathol 28: 644-650. (Pubitemid 38579568)
9. Michl P, Barth C, Buchholz M, Lerch MM, Rolke M, Holzmann KH, et al, (2003) Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer. Cancer Res 63: 6265-6271. (Pubitemid 37255173)
10. Morin PJ, (2005) Claudin proteins in human cancer: promising new targets for diagnosis and therapy. Cancer Res 65: 9603-9606. (Pubitemid 41541431)
11. Ohtani S, Terashima M, Satoh J, Soeta N, Saze Z, Kashimura S, et al, (2009) Expression of tight-junction-associated proteins in human gastric cancer: downregulation of claudin-4 correlates with tumor aggressiveness and survival. Gastric Cancer 12: 43-51.
12. Ouban A, Ahmed AA, (2010) Claudins in human cancer: a review. Histol Histopathol 25: 83-90.
13. Schneppenheim R, Frühwald MC, Gesk S, Hasselblatt M, Jeibmann A, Kordes U, et al, (2010) Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome. Am J Hum Genet 86: 279-284.
14. Swisshelm K, Macek R, Kubbies M, (2005) Role of claudins in tumorigenesis. Adv Drug Deliv Rev 25: 919-928. (Pubitemid 40488110)
15. Turunen M, Talvensaari-Mattila A, Soini Y, Santala M, (2009) Claudin-5 overexpression correlates with aggressive behavior in serous ovarian adenocarcinoma. Anticancer Res 29: 5185-5189.